div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails5jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails6jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails7jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=8Page 8button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=8 data-page=8 class=ts-thumb lazyload alt=Page 8: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails8jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=9Page 9button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=9 data-page=9 class=ts-thumb lazyload alt=Page 9: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails9jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=10Page 10button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=10 data-page=10 class=ts-thumb lazyload alt=Page 10: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails10jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=11Page 11button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=11 data-page=11 class=ts-thumb lazyload alt=Page 11: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails11jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=12Page 12button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=12 data-page=12 class=ts-thumb lazyload alt=Page 12: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails12jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=13Page 13button div class=ts-imageimg data-url=planning-ipilimumab-therapy-in-a-single-institution-dr-ruggero-ridolfihtmlpage=13 data-page=13 class=ts-thumb lazyload alt=Page 13: · Planning Ipilimumab therapy in a single institution Dr Ruggero Ridolfi B Raf inhibitors: from pipeline to market Dottssa Luisa Veronese From pipeline to clinical research loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentsnetreader030viewer20220404215e0e6106a4c4211adb517ab6html5thumbnails13jpg width=140 height=200 divdiv
